What is the maximum daily dosing of midodrine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Daily Dosing of Midodrine

The maximum daily dose of midodrine is 30 mg, typically administered as 10 mg three times daily, with the last dose taken no later than 6 PM to avoid supine hypertension during sleep. 1

Dosing Guidelines

Standard Dosing

  • Starting dose: 10 mg three times daily 1
  • Dosing intervals: Approximately 4 hours apart (e.g., morning, midday, late afternoon) 1
  • Alternative interval: Can be given at 3-hour intervals if needed for symptom control, but not more frequently 1
  • Maximum single dose: 20 mg has been given to patients, but causes severe and persistent supine hypertension in about 45% of cases 1

Timing Considerations

  • Last dose should be taken no later than 6 PM 1
  • Doses should not be given less than 4 hours before bedtime 1
  • Medication should be taken during daytime hours when the patient needs to be upright 1

Special Populations

  • Renal impairment: Start with 2.5 mg doses in patients with abnormal renal function 1
  • Elderly patients: No dose modifications necessary based on age 1
  • Gender: No dose adjustments needed based on gender 1

Clinical Applications and Alternative Dosing

Hepatorenal Syndrome

When used for hepatorenal syndrome in combination with octreotide:

  • Starting dose: 7.5 mg three times daily 2
  • Can be titrated up to 12.5 mg three times daily if needed 2

Orthostatic Hypotension

  • Typical dosing range: 5-20 mg three times daily 3, 4
  • Efficacy demonstrated at 10 mg three times daily for orthostatic hypotension 4

Higher Frequency Dosing

Some evidence suggests that increasing dosing frequency to every 6 hours may optimize the pharmacokinetic profile without compromising safety, particularly in critical care settings 5. However, this exceeds the FDA-approved dosing frequency.

Safety Considerations

Monitoring Requirements

  • Regular monitoring of supine and standing blood pressure is essential 1
  • Discontinue if supine blood pressure increases excessively 1
  • Risk of supine hypertension occurs in up to 25% of patients 6

Common Side Effects

  • Piloerection (goosebumps)
  • Pruritus (itching)
  • Paresthesias
  • Urinary retention
  • Chills 6

Contraindications

  • Severe cardiac disease
  • Acute kidney injury with serum creatinine ≥5 mg/dL 3
  • Severe supine hypertension

Important Precautions

  • Total daily doses exceeding 30 mg have been tolerated by some patients but safety and efficacy have not been systematically established 1
  • One case report documented a patient tolerating up to 90 mg daily (60 mg maintenance plus 30 mg intradialytic doses) for treprostinil-induced hypotension, but this is far outside standard dosing and should not be considered routine practice 7
  • Continue treatment only in patients who demonstrate symptomatic improvement during initial treatment 1

While some patients may tolerate higher doses in specific clinical scenarios, the maximum FDA-approved daily dose remains 30 mg, and exceeding this should be approached with extreme caution and close monitoring.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Midodrine Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Midodrine treatment in a patient with treprostinil-induced hypotension receiving hemodialysis.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.